Mydecine Innovations Group, Inc. (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA)
(i) number of securities in issue and the percentage of securities in public hands (updated at the same time as announcing information pursuant to Rule 2.13).
(ii) the particulars of any outstanding instruments issued by the issuer convertible into, or conferring a right to subscribe for, the admitted securities; the amount and percentage of immediate dilution assuming full exercise of rights of conversion;
(iii) a list of the shareholders holding more than five per cent of the issuer’s share capital or voting rights and the percentage held by such shareholders;
(iv) any restrictions on their transfer;
(v) details of the exchanged or trading platforms on which they are admitted to trading.
Suite 1890 – 1075 West Georgia Street
Vancouver, BC, V6E 3C9
Copyright © 2024 Mydecine Innovations Group - All Rights Reserved.